Form 4: Masimo Corp CEO Joe E. Kiani Executes Stock Option and Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Joe E. Kiani, CEO and Chairman of the Board of Masimo Corp, exercised a non-qualified stock option and reported changes in his beneficial ownership of company stock.
Summary
- On August 8, 2024, Joe E. Kiani, CEO and Chairman of the Board of Masimo Corporation, executed a transaction involving company stock.
- Kiani exercised a non-qualified stock option to acquire 231,748 shares of common stock at a price of $37.84 per share.
- Following the transaction, Kiani's directly held derivative securities decreased to 68,252.
- Kiani's total beneficial ownership of Masimo common stock, including shares held directly and indirectly through various trusts and a retirement savings plan, is 3,596,401.
- The report also details the nature of indirect beneficial ownership through several trusts, including those where Kiani is not the sole trustee.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't convey any explicit positive or negative sentiment about the company's performance or prospects.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedule of the option (20% per year over 5 years) is a common practice to incentivize long-term commitment.
- Similar filings are made by executives at comparable medical technology companies like Medtronic and Stryker, detailing their stock transactions and ownership positions.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive stock ownership.
- The exercise of stock options can have a dilutive effect on existing shareholders, although the impact is likely minimal in this case.
Key Dates
| Date | Description |
|---|---|
| 02/29/2016 | Date the non-qualified stock option was granted. |
| 08/08/2024 | Date of the stock option exercise and reported transaction. |
| 08/12/2024 | Date of the Form 4 filing. |
| 02/28/2026 | Expiration date of the non-qualified stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.